Tissue-specific DNA methylation variability and its potential clinical value

Area of Science:

• Epigenetics and Genomics
• Complex Disease Biomarkers
• Systems Biology Approaches

Background:

• Complex diseases present diagnostic challenges due to multifactorial etiologies.
• Current diagnostic biomarkers often focus on limited genetic or epigenetic targets.
• A systems-level approach analyzing biological pathways is needed for complex diseases.

Purpose of the Study:

• To develop a diagnostic tool for analyzing comprehensive epigenetic profiles in complex diseases.
• To measure intra-individual methylation variability within gene promoters to detect global regulatory shifts.
• To assess tissue-specificity, disease-associated alterations, and clinical utility of epigenetic variability.

Main Methods:

• Utilized publicly available DNA methylation data from over 2,400 samples across 20 cell types and various diseases.
• Developed a tool to measure intra-individual methylation variability in gene promoters, not just differentially methylated regions.
• Employed unsupervised clustering to analyze epigenetic variability patterns.

Main Results:

• Global epigenetic variability in promoter regions is tissue-specific.
• Diseased tissues exhibit altered epigenetic variability compared to normal tissues.
• Epigenetic variability analysis successfully distinguished between diseased and normal tissues in multiple complex diseases.

Conclusions:

• Epigenetic variability in gene promoters serves as a sensitive indicator of cellular regulatory state.
• The developed tool demonstrates clinical utility in assessing multifactorial conditions like male infertility.
• Sperm epigenetic variability correlates with live birth success in intrauterine insemination (IUI), offering potential reproductive insights.